INCY · Categories · Upgrades
INCY - Analyst upgrades
Incyte Corp. (INCY) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for INCY
- Incyte upgraded by BMO Capital Markets with a new price targetBMO Capital Markets upgraded Incyte from Underperform to Market Perform and set a new price target of $94.00
- Incyte upgraded by Mizuho with a new price targetMizuho upgraded Incyte from Neutral to Outperform and set a new price target of $121.00
- Incyte upgraded by Guggenheim with a new price targetGuggenheim upgraded Incyte from Neutral to Buy and set a new price target of $125.00
- Incyte upgraded by Wells Fargo with a new price targetWells Fargo upgraded Incyte from Equal Weight to Overweight and set a new price target of $89.00
- Incyte upgraded by Stifel with a new price targetStifel upgraded Incyte from Hold to Buy and set a new price target of $107.00
- Incyte upgraded by BofA Securities with a new price targetBofA Securities upgraded Incyte from Neutral to Buy and set a new price target of $90.00 from $68.00 previously
- Incyte upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Incyte from Market Perform to Outperform and set a new price target of $78.00
- Incyte upgraded by Guggenheim with a new price targetGuggenheim upgraded Incyte from Neutral to Buy and set a new price target of $86.00
- Incyte upgraded by SVB Securities with a new price targetSVB Securities upgraded Incyte from Underperform to Market Perform and set a new price target of $61.00
- Incyte upgraded by RBC Capital with a new price targetRBC Capital upgraded Incyte from Sector Perform to Outperform and set a new price target of $90.00 from $78.00 previously
- Incyte upgraded by SVB Leerink with a new price targetSVB Leerink upgraded Incyte from Underperform to Market Perform and set a new price target of $66.00 from $67.00 previously
- Incyte upgraded by Benchmark with a new price targetBenchmark upgraded Incyte from Hold to Buy and set a new price target of $89.00
- Incyte upgraded by The Benchmark Company with a new price targetThe Benchmark Company upgraded Incyte from Hold to Buy and set a new price target of $89.00